---
qid: ing_bd554e02a9__think__local
question: 'Our audio is a clinic room: two or three speakers, background noise, accents,
  and a vocabulary full of drug names. How would you build and improve the ASR for
  that?'
topic: AI
model: openai/gpt-oss-20b
provider: lmstudio
input_tokens: 215
output_tokens: 502
total_tokens: 717
web_searches: 0
cost_usd: 0.0
generated_at: '2026-09-06T13:27:58-05:00'
sources: []
---

**1. Clarify goals & constraints**  
   - *What* is the success metric? (WER, real‑time factor)  
   - *Where* will it run? (edge device vs cloud)  
   - *Who* are the speakers? (do we need speaker diarization?)  
   - List key vocabularies: drug names, medical acronyms, common accents.  

**2. Adopt a layered framework**  
   1. **Front‑end signal processing** – robust noise suppression & dereverberation.  
   2. **Acoustic model (AM)** – transfer‑learned from large general corpora + fine‑tune on in‑domain audio.  
   3. **Language model (LM)** – n‑gram or Transformer trained on clinical transcripts, enriched with drug dictionaries.  
   4. **Post‑processing** – custom spell‑checker / medical term normalizer.  

**3. Step‑by‑step reasoning**  
   - Collect a modest amount of annotated clinic recordings; augment via speed/pitch change and synthetic noise.  
   - Train a multilingual wav2vec/Conformer AM, then adapt with the in‑domain data.  
   - Build a domain LM: start with an n‑gram, then experiment with a small BERT/Transformer for better context on drug names.  
   - Integrate speaker diarization if multiple speakers are frequent; else assume single‑speaker model.  
   - Evaluate on held‑out clinic audio, iterate on noise models and LM coverage.  

**4. Avoid common traps**  
   - Don’t over‑clean the signal: aggressive denoising can remove phonetic cues.  
   - Don’t ignore accents—include diverse speaker samples early.  
   - Beware of “hallucinated” drug names from a weak LM; enforce medical dictionary constraints.  

**5. Sanity‑check & communicate**  
   - Verify that WER drops when adding domain data; check confusion matrices for drug name errors.  
   - Present incremental improvements: baseline → AM fine‑tune → LM upgrade → post‑processing, each with quantitative gains.  
   - Highlight trade‑offs (latency vs accuracy) and next steps (real‑time deployment, continuous learning).

_Written by openai/gpt-oss-20b running locally. Machine-generated, not reviewed._
